On Monday, Pacific Biosciences of California Inc (NASDAQ: PACB) opened lower -4.29% from the last session, before settling in for the closing price of $2.10. Price fluctuations for PACB have ranged from $1.16 to $7.85 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 26.71%. Company’s average yearly earnings per share was noted -11.78% at the time writing. With a float of $241.81 million, this company’s outstanding shares have now reached $273.81 million.
The extent of productivity of a business whose workforce counts for 796 workers is very important to gauge. In terms of profitability, gross margin is 18.12%, operating margin of -215.33%, and the pretax margin is -228.11%.
Pacific Biosciences of California Inc (PACB) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pacific Biosciences of California Inc is 11.70%, while institutional ownership is 83.22%. The most recent insider transaction that took place on Jan 10 ’25, was worth 69,980. In this transaction an insider of this company sold 34,405 shares at a rate of $2.03, taking the stock ownership to the 1,597,454 shares. Before that another transaction happened on Jan 10 ’25, when Company’s Officer proposed sale 34,405 for $2.03, making the entire transaction worth $69,980.
Pacific Biosciences of California Inc (PACB) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -11.78% per share during the next fiscal year.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Check out the current performance indicators for Pacific Biosciences of California Inc (PACB). In the past quarter, the stock posted a quick ratio of 8.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
The latest stats from [Pacific Biosciences of California Inc, PACB] show that its last 5-days average volume of 11.22 million was superior to 10.01 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 69.39%. Additionally, its Average True Range was 0.18.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 51.03%, which indicates a significant decrease from 57.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.34% in the past 14 days, which was lower than the 97.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.02, while its 200-day Moving Average is $1.89. Now, the first resistance to watch is $2.09. This is followed by the second major resistance level at $2.18. The third major resistance level sits at $2.25. If the price goes on to break the first support level at $1.93, it is likely to go to the next support level at $1.86. The third support level lies at $1.77 if the price breaches the second support level.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
There are currently 273,864K shares outstanding in the company with a market cap of 550.46 million. Presently, the company’s annual sales total 200,520 K according to its annual income of -306,740 K. Last quarter, the company’s sales amounted to 39,970 K and its income totaled -60,730 K.
